Literature DB >> 24021575

Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury.

Masaru Yoshizumi1, James C Eisenach, Ken-ichiro Hayashida.   

Abstract

UNLABELLED: The present study examined whether the histone deacetylase inhibitor valproate prevents downregulation of glutamate transporters in the primary cultured astrocytes and in the spinal cord after L5-L6 spinal nerve ligation (SNL) and whether this action of valproate on spinal glutamate transporters prevents spinal glutamate dysregulation and development of hypersensitivity after SNL. In cultured astrocytes, valproate prevented downregulation of glutamate transporter-1 (GLT-1) and glutamate-aspartate transporter in a concentration-dependent manner. Repeated oral administration of valproate reduced the development of hypersensitivity and prevented the downregulation of spinal GLT-1 and glutamate-aspartate transporter expression in rats after SNL, but did not affect mechanical nociception and expression of those transporters in normal rats. Valproate's effects on hypersensitivity and spinal GLT-1 expression in SNL rats were blocked by intrathecal administration of the selective GLT-1 blocker dihydrokainic acid or the GLT-1 selective small interfering RNA (siRNA). Extracellular glutamate concentration in the spinal cord, measured by microdialysis, was increased in animals with SNL or after GLT-1 selective siRNA treatment, and valproate prevented the SNL-induced glutamate increase. These results suggest that valproate reduces the development of chronic pain after nerve injury in part by preventing downregulation of glutamate transporters, especially GLT-1, to maintain normal extracellular glutamate concentrations in the spinal cord. PERSPECTIVE: This study demonstrates that valproate prevents the downregulation of glutamate transporters in the spinal cord, which contributes in part to the development of chronic pain after nerve injury. Given clinical availability and established safety profiles, perioperative use of valproate should be tested to prevent chronic pain after surgery.
Copyright © 2013 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Valproate; astrocyte; chronic pain; glutamate transporter; spinal cord

Mesh:

Substances:

Year:  2013        PMID: 24021575      PMCID: PMC3818435          DOI: 10.1016/j.jpain.2013.07.007

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  24 in total

1.  Downregulation of glutamate transporters is associated with elevation in extracellular glutamate concentration following rat microsphere embolism.

Authors:  Feng Han; Norifumi Shioda; Shigeki Moriguchi; Zheng-Hong Qin; Kohji Fukunaga
Journal:  Neurosci Lett       Date:  2007-11-19       Impact factor: 3.046

Review 2.  The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype.

Authors:  M B Robinson
Journal:  Neurochem Int       Date:  1998-12       Impact factor: 3.921

3.  Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia.

Authors:  G Gegelashvili; N C Danbolt; A Schousboe
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

4.  Glutamate uptake is attenuated in spinal deep dorsal and ventral horn in the rat spinal nerve ligation model.

Authors:  Brian C Binns; Y Huang; Virginia M Goettl; Kevin V Hackshaw; Robert L Stephens
Journal:  Brain Res       Date:  2005-04-11       Impact factor: 3.252

5.  Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors:  J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

6.  Neuronal regulation of glutamate transporter subtype expression in astrocytes.

Authors:  R A Swanson; J Liu; J W Miller; J D Rothstein; K Farrell; B A Stein; M C Longuemare
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

Review 7.  Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.

Authors:  P M Beart; R D O'Shea
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

8.  Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.

Authors:  D K Kochar; P Garg; R A Bumb; S K Kochar; R D Mehta; R Beniwal; N Rawat
Journal:  QJM       Date:  2005-01

9.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

10.  Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1.

Authors:  Gisela Aguirre; Sandra Rosas; Esther López-Bayghen; Arturo Ortega
Journal:  Neurochem Int       Date:  2008-02-08       Impact factor: 3.921

View more
  9 in total

Review 1.  [Epigenetics : Important aspects for anesthesiologists, pain and intensive care physicians].

Authors:  A-K Reinhold; E Jentho; S T Schäfer; M Bauer; H L Rittner
Journal:  Anaesthesist       Date:  2018-04       Impact factor: 1.041

Review 2.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

3.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

4.  Gabapentin increases extracellular glutamatergic level in the locus coeruleus via astroglial glutamate transporter-dependent mechanisms.

Authors:  Takashi Suto; Amie L Severino; James C Eisenach; Ken-ichiro Hayashida
Journal:  Neuropharmacology       Date:  2014-02-01       Impact factor: 5.250

Review 5.  Epigenetic regulation of persistent pain.

Authors:  Guang Bai; Ke Ren; Ronald Dubner
Journal:  Transl Res       Date:  2014-05-29       Impact factor: 7.012

6.  Valproate reverses stress-induced somatic hyperalgesia and visceral hypersensitivity by up-regulating spinal 5-HT2C receptor expression in female rats.

Authors:  Gang-Zhu Xu; Yang Xue; Si-Qi Wei; Jia-Heng Li; Richard J Traub; Mao-De Wang; Dong-Yuan Cao
Journal:  Neuropharmacology       Date:  2019-12-26       Impact factor: 5.250

7.  Gabapentin loses efficacy over time after nerve injury in rats: role of glutamate transporter-1 in the locus coeruleus.

Authors:  Masafumi Kimura; James C Eisenach; Ken-Ichiro Hayashida
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

8.  Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug.

Authors:  Shota Yamamoto; Soichiro Ushio; Nobuaki Egashira; Takehiro Kawashiri; Shohei Mitsuyasu; Hitomi Higuchi; Nana Ozawa; Ken Masuguchi; Yuko Ono; Satohiro Masuda
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

Review 9.  The etiological changes of acetylation in peripheral nerve injury-induced neuropathic hypersensitivity.

Authors:  Xian Wang; Xiaofeng Shen; Yingli Xu; Shiqin Xu; Fan Xia; Bei Zhu; Yusheng Liu; Wei Wang; Haibo Wu; Fuzhou Wang
Journal:  Mol Pain       Date:  2018-08-14       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.